zb004
Generic: CTLA-4-Ig fusion
zb004: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Zenas BioPharma, Inc. (ZBIO) | Phase 1 |
Clinical Trials (1)
A Single Ascending Dose (SAD) Study to Evaluate the Safety and Pharmacokinetics (PK) of ZB004 in Healthy Volunteers
Frequently asked questions
Who is developing zb004?
zb004 is being developed by Zenas BioPharma, Inc..
How many clinical trials involve zb004?
BioSniper tracks 1 clinical trial involving zb004.
Get deeper analysis on zb004
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis